Drawing for PRO PASS

USPTO serial 97542761

PRO PASS

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
Examiner
RHIM, ANDREW
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with PRO PASS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $224*

Plus Government fees of $125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Heisler Lavalley

Jennifer Heisler Lavalley GTC LAW GROUP PC & AFFILIATESOne University Ave., Ste 302BWestwood, MA 02090United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and project management in the field of clinical trials, namely, providing business information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, business management of clinical trial execution; providing technical consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials, clinical trial subject recruitment and enrollment for clinical trials, and processing business documents relating to clinical trials, and information management services, namely, clinical data management to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data for business purposes; statistical analysis for business purposes; providing referrals of subjects for enrollment in clinical trialsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (EEXT): The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.

DateCodeEventWhat it means
Aug 7, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 8, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 8, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2026EX4GSOU EXTENSION 4 GRANTED
Feb 19, 2026EXT4SOU EXTENSION 4 FILED
Feb 19, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2025EX3GSOU EXTENSION 3 GRANTED
Aug 28, 2025EXT3SOU EXTENSION 3 FILED
Aug 28, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025EX2GSOU EXTENSION 2 GRANTED
Mar 4, 2025EXT2SOU EXTENSION 2 FILED
Mar 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2024EX1GSOU EXTENSION 1 GRANTED
Sep 10, 2024EXT1SOU EXTENSION 1 FILED
Sep 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 19, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 19, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 9, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 5, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2023DOCKASSIGNED TO EXAMINER
Aug 16, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance